SIMILAR PATTERNS OF AMINO ACIDS FOR 3GY3_A_PNTA246_0
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1a0j | TRYPSIN (Salmo salar) |
PF00089(Trypsin) | 8 | HIS A 57ASP A 189SER A 190GLN A 192SER A 195TRP A 215GLY A 216GLY A 226 | SO4 A 248 (-3.9A)BEN A 246 (-3.0A)BEN A 246 (-3.0A)NoneSO4 A 248 ( 2.5A)NoneBEN A 246 ( 3.9A)BEN A 246 (-3.3A) | 0.61A | 3gy3A-1a0jA:40.0 | 3gy3A-1a0jA:73.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1a0j | TRYPSIN (Salmo salar) |
PF00089(Trypsin) | 9 | HIS A 57LEU A 99GLN A 175ASP A 189SER A 190SER A 195TRP A 215GLY A 216GLY A 226 | SO4 A 248 (-3.9A)NoneNoneBEN A 246 (-3.0A)BEN A 246 (-3.0A)SO4 A 248 ( 2.5A)NoneBEN A 246 ( 3.9A)BEN A 246 (-3.3A) | 0.45A | 3gy3A-1a0jA:40.0 | 3gy3A-1a0jA:73.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1a5i | PLASMINOGENACTIVATOR (Desmodusrotundus) |
PF00089(Trypsin) | 7 | HIS A 57ASP A 189GLN A 192SER A 195TRP A 215GLY A 216GLY A 226 | 0GJ A 245 (-2.7A)0GJ A 245 (-3.1A)0GJ A 245 (-3.5A)0GJ A 245 (-1.4A)None0GJ A 245 (-3.5A)0GJ A 245 ( 4.2A) | 0.57A | 3gy3A-1a5iA:11.4 | 3gy3A-1a5iA:37.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1afq | BOVINEGAMMA-CHYMOTRYPSIN (Bos taurus) |
PF00089(Trypsin) | 5 | SER C 190SER C 195TRP C 215GLY C 216GLY C 226 | None0FG C 301 ( 3.0A)None0FG C 301 (-3.4A)0FG C 301 ( 4.4A) | 0.58A | 3gy3A-1afqC:11.2 | 3gy3A-1afqC:22.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ao5 | GLANDULARKALLIKREIN-13 (Mus musculus) |
PF00089(Trypsin) | 5 | HIS A 57GLN A 174ASP A 189SER A 195GLY A 216 | None | 0.81A | 3gy3A-1ao5A:13.4 | 3gy3A-1ao5A:37.82 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1bqy | PLASMINOGENACTIVATOR (Trimeresurusstejnegeri) |
PF00089(Trypsin) | 6 | HIS A 57ASP A 189SER A 195TRP A 215GLY A 216GLY A 226 | 0GJ A 1 ( 2.7A)0GJ A 1 (-3.1A)0GJ A 1 ( 1.4A)None0GJ A 1 (-3.5A)0GJ A 1 ( 4.3A) | 0.48A | 3gy3A-1bqyA:34.1 | 3gy3A-1bqyA:42.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1bru | ELASTASE (Sus scrofa) |
PF00089(Trypsin) | 5 | HIS P 57LEU P 99SER P 190SER P 195GLY P 216 | 1NB P 1 (-3.9A)None1NB P 1 (-3.5A)1NB P 1 ( 1.2A)1NB P 1 ( 4.4A) | 0.74A | 3gy3A-1bruP:16.8 | 3gy3A-1bruP:40.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1cle | CHOLESTEROL ESTERASE ([Candida]cylindracea) |
PF00135(COesterase) | 5 | GLN A 456SER A 214TRP A 119GLY A 207GLY A 211 | None | 1.15A | 3gy3A-1cleA:undetectable | 3gy3A-1cleA:18.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1crl | LIPASE (Diutina rugosa) |
PF00135(COesterase) | 5 | GLN A 456SER A 214TRP A 119GLY A 207GLY A 211 | None | 1.11A | 3gy3A-1crlA:undetectable | 3gy3A-1crlA:19.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1dlk | THROMBIN HEAVY CHAIN (Bos taurus) |
PF00089(Trypsin) | 6 | HIS B 57SER B 190SER B 195TRP B 215GLY B 216GLY B 226 | None | 0.67A | 3gy3A-1dlkB:35.8 | 3gy3A-1dlkB:43.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ecg | GLUTAMINEPHOSPHORIBOSYLPYROPHOSPHATEAMIDOTRANSFERASE (Escherichiacoli) |
PF00156(Pribosyltran)PF13522(GATase_6) | 5 | LEU A 104GLN A 86GLY A 102CYH A 1GLY A 406 | NoneONL A 505 (-4.2A)ONL A 505 (-3.7A)ONL A 505 ( 1.8A)ONL A 505 ( 4.2A) | 1.12A | 3gy3A-1ecgA:undetectable | 3gy3A-1ecgA:19.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ecg | GLUTAMINEPHOSPHORIBOSYLPYROPHOSPHATEAMIDOTRANSFERASE (Escherichiacoli) |
PF00156(Pribosyltran)PF13522(GATase_6) | 5 | LEU A 104SER A 126GLY A 102CYH A 1GLY A 406 | NoneONL A 505 (-2.7A)ONL A 505 (-3.7A)ONL A 505 ( 1.8A)ONL A 505 ( 4.2A) | 1.15A | 3gy3A-1ecgA:undetectable | 3gy3A-1ecgA:19.03 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ekb | ENTEROPEPTIDASE (Bos taurus) |
PF00089(Trypsin) | 7 | HIS B 57ASP B 189SER B 190GLN B 192SER B 195GLY B 216GLY B 226 | None | 0.42A | 3gy3A-1ekbB:36.7 | 3gy3A-1ekbB:36.71 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1elv | COMPLEMENT C1SCOMPONENT (Homo sapiens) |
PF00084(Sushi)PF00089(Trypsin) | 7 | HIS A 460ASP A 611SER A 612SER A 617TRP A 640GLY A 641GLY A 648 | SO4 A2001 ( 3.9A)NoneNoneSO4 A2001 ( 2.7A)NoneNoneNone | 0.38A | 3gy3A-1elvA:11.1 | 3gy3A-1elvA:30.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ept | PORCINE E-TRYPSINPORCINE E-TRYPSINPORCINE E-TRYPSIN (Sus scrofa;Sus scrofa;Sus scrofa) |
PF00089(Trypsin)PF00089(Trypsin)PF00089(Trypsin) | 9 | HIS A 57LEU B 99ASP C 189SER C 190GLN C 192SER C 195TRP C 215GLY C 216GLY C 226 | None | 0.41A | 3gy3A-1eptA:4.4 | 3gy3A-1eptA:90.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ept | PORCINE E-TRYPSINPORCINE E-TRYPSINPORCINE E-TRYPSIN (Sus scrofa;Sus scrofa;Sus scrofa) |
PF00089(Trypsin)PF00089(Trypsin)PF00089(Trypsin) | 9 | HIS A 57LEU B 99GLN C 175ASP C 189SER C 190SER C 195TRP C 215GLY C 216GLY C 226 | None | 0.55A | 3gy3A-1eptA:4.4 | 3gy3A-1eptA:90.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1euf | DUODENASE (Bos taurus) |
PF00089(Trypsin) | 5 | HIS A 57LEU A 99SER A 190SER A 195GLY A 216 | None | 0.54A | 3gy3A-1eufA:16.7 | 3gy3A-1eufA:38.43 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1fiw | BETA-ACROSIN HEAVYCHAIN (Ovis aries) |
PF00089(Trypsin) | 6 | ASP A 189GLN A 192SER A 195TRP A 215GLY A 216GLY A 226 | PBZ A 305 (-2.7A)PBZ A 305 (-3.2A)PBZ A 305 (-2.9A)NonePBZ A 305 (-3.4A)PBZ A 305 (-3.3A) | 0.81A | 3gy3A-1fiwA:16.4 | 3gy3A-1fiwA:34.60 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1fiw | BETA-ACROSIN HEAVYCHAIN (Ovis aries) |
PF00089(Trypsin) | 6 | HIS A 57ASP A 189SER A 195TRP A 215GLY A 216GLY A 226 | NonePBZ A 305 (-2.7A)PBZ A 305 (-2.9A)NonePBZ A 305 (-3.4A)PBZ A 305 (-3.3A) | 0.37A | 3gy3A-1fiwA:16.4 | 3gy3A-1fiwA:34.60 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1fiz | BETA-ACROSIN HEAVYCHAIN (Sus scrofa) |
PF00089(Trypsin) | 7 | HIS A 57ASP A 189GLN A 192SER A 195TRP A 215GLY A 216GLY A 226 | NonePBZ A 308 (-2.9A)PBZ A 308 (-3.6A)PBZ A 308 (-3.2A)NonePBZ A 308 (-3.6A)PBZ A 308 ( 3.7A) | 0.56A | 3gy3A-1fizA:16.9 | 3gy3A-1fizA:37.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1fxy | COAGULATION FACTORXA-TRYPSIN CHIMERA (Homo sapiens) |
PF00089(Trypsin) | 8 | HIS A 57ASP A 189SER A 190GLN A 192SER A 195TRP A 215GLY A 216GLY A 226 | 0G6 A 1 (-2.7A)0G6 A 1 (-2.8A)0G6 A 1 (-2.8A)0G6 A 1 (-3.8A)0G6 A 1 (-1.4A)None0G6 A 1 (-3.9A)0G6 A 1 (-3.3A) | 0.48A | 3gy3A-1fxyA:37.0 | 3gy3A-1fxyA:55.46 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1gvl | KALLIKREIN 6 (Homo sapiens) |
PF00089(Trypsin) | 5 | HIS A 57SER A 195TRP A 215GLY A 216GLY A 226 | None | 0.57A | 3gy3A-1gvlA:27.6 | 3gy3A-1gvlA:44.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1gz7 | LIPASE 2 (Diutina rugosa) |
PF00135(COesterase) | 5 | GLN A 456SER A 214TRP A 119GLY A 207GLY A 211 | None | 1.17A | 3gy3A-1gz7A:undetectable | 3gy3A-1gz7A:19.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1h4w | TRYPSIN IVA (Homo sapiens) |
PF00089(Trypsin) | 9 | HIS A 57LEU A 99ASP A 189SER A 190GLN A 192SER A 195TRP A 215GLY A 216GLY A 226 | NoneNoneBEN A 250 (-2.9A)BEN A 250 (-2.9A)BEN A 250 (-3.8A)BEN A 250 (-3.6A)NoneBEN A 250 (-3.9A)BEN A 250 (-3.3A) | 0.69A | 3gy3A-1h4wA:41.4 | 3gy3A-1h4wA:72.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1h9h | TRYPSIN (Sus scrofa) |
PF00089(Trypsin) | 10 | HIS E 57LEU E 99GLN E 175ASP E 189SER E 190GLN E 192SER E 195TRP E 215GLY E 216GLY E 226 | None | 0.47A | 3gy3A-1h9hE:43.3 | 3gy3A-1h9hE:82.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1id5 | THROMBIN (Bos taurus) |
PF00089(Trypsin) | 6 | HIS H 57ASP H 189SER H 195TRP H 215GLY H 216GLY H 226 | None | 0.53A | 3gy3A-1id5H:32.7 | 3gy3A-1id5H:37.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1id5 | THROMBIN (Bos taurus) |
PF00089(Trypsin) | 6 | LEU H 99ASP H 189SER H 195TRP H 215GLY H 216GLY H 226 | None | 0.94A | 3gy3A-1id5H:32.7 | 3gy3A-1id5H:37.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1j17 | TRYPSIN II, ANIONIC (Rattusnorvegicus) |
PF00089(Trypsin) | 6 | HIS T 57ASP T 189SER T 195TRP T 215GLY T 216GLY T 226 | SO4 T 600 (-3.8A)ZEN T 1 ( 3.8A)SO4 T 600 ( 2.6A)ZEN T 1 (-3.4A)ZEN T 1 (-3.7A)ZEN T 1 (-3.7A) | 0.29A | 3gy3A-1j17T:41.7 | 3gy3A-1j17T:71.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1kig | FACTOR XA (Bos taurus) |
PF00089(Trypsin) | 6 | HIS H 57ASP H 189SER H 195TRP H 215GLY H 216GLY H 226 | None | 0.49A | 3gy3A-1kigH:12.3 | 3gy3A-1kigH:40.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1kig | FACTOR XA (Bos taurus) |
PF00089(Trypsin) | 5 | HIS H 57GLN H 192SER H 195TRP H 215GLY H 216 | None | 0.90A | 3gy3A-1kigH:12.3 | 3gy3A-1kigH:40.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1mbq | TRYPSIN (Oncorhynchusketa) |
PF00089(Trypsin) | 7 | HIS A 57ASP A 189SER A 190SER A 195TRP A 215GLY A 216GLY A 226 | NoneBEN A1222 (-2.9A)BEN A1222 (-2.9A)BEN A1222 (-3.5A)NoneBEN A1222 (-3.9A)BEN A1222 (-3.4A) | 0.34A | 3gy3A-1mbqA:39.9 | 3gy3A-1mbqA:65.61 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1mkx | PRETHROMBIN-2 (Bos taurus) |
PF00089(Trypsin)PF09396(Thrombin_light) | 6 | HIS K 57LEU K 99SER K 195TRP K 215GLY K 216GLY K 226 | None | 1.03A | 3gy3A-1mkxK:8.3 | 3gy3A-1mkxK:37.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1npm | NEUROPSIN (Mus musculus) |
PF00089(Trypsin) | 6 | HIS A 57ASP A 189SER A 195TRP A 215GLY A 216GLY A 226 | None | 0.50A | 3gy3A-1npmA:36.8 | 3gy3A-1npmA:45.58 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1o5f | SERINE PROTEASEHEPSIN (Homo sapiens) |
PF00089(Trypsin) | 7 | HIS H 57GLN H 175ASP H 189SER H 195TRP H 215GLY H 216GLY H 226 | CR9 H 256 (-3.9A)NoneCR9 H 256 (-2.4A)CR9 H 256 (-1.5A)NoneCR9 H 256 ( 3.8A)CR9 H 256 (-3.0A) | 0.63A | 3gy3A-1o5fH:18.6 | 3gy3A-1o5fH:41.11 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1op2 | VENOM SERINEPROTEINASE (Deinagkistrodonacutus) |
PF00089(Trypsin) | 5 | HIS A 57ASP A 189SER A 195GLY A 216GLY A 226 | None | 0.53A | 3gy3A-1op2A:33.2 | 3gy3A-1op2A:41.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1orf | GRANZYME A (Homo sapiens) |
PF00089(Trypsin) | 6 | HIS A 57ASP A 189SER A 190SER A 195GLY A 216GLY A 226 | 0G6 A 1 (-2.7A)0G6 A 1 (-2.9A)0G6 A 1 (-2.9A)0G6 A 1 (-1.3A)0G6 A 1 (-3.3A)0G6 A 1 (-3.5A) | 0.39A | 3gy3A-1orfA:12.6 | 3gy3A-1orfA:35.02 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1pfx | FACTOR IXA (Sus scrofa) |
PF00089(Trypsin) | 7 | HIS C 57ASP C 189SER C 190SER C 195TRP C 215GLY C 216GLY C 226 | 0G6 C 301 (-2.5A)0G6 C 301 (-3.0A)0G6 C 301 (-2.6A)0G6 C 301 (-1.4A)None0G6 C 301 (-3.2A)0G6 C 301 ( 3.5A) | 0.51A | 3gy3A-1pfxC:9.9 | 3gy3A-1pfxC:43.64 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1pq5 | TRYPSIN (Fusariumoxysporum) |
PF00089(Trypsin) | 8 | HIS A 56ASP A 189SER A 190GLN A 192SER A 195TRP A 212GLY A 213GLY A 223 | ARG A 703 (-4.3A)ARG A 703 (-2.0A)ARG A 703 (-2.5A)ARG A 703 (-3.1A)ARG A 703 (-2.3A)NoneARG A 703 ( 3.7A)ARG A 703 (-2.6A) | 0.36A | 3gy3A-1pq5A:34.3 | 3gy3A-1pq5A:44.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1q3x | MANNAN-BINDINGLECTIN SERINEPROTEASE 2 (Homo sapiens) |
PF00084(Sushi)PF00089(Trypsin) | 7 | HIS A 483ASP A 627SER A 628SER A 633TRP A 655GLY A 656GLY A 667 | None NA A 800 ( 4.6A)GOL A 701 (-3.4A)GOL A 701 (-3.0A)NoneGOL A 701 ( 4.1A)GOL A 701 ( 4.0A) | 0.30A | 3gy3A-1q3xA:33.6 | 3gy3A-1q3xA:29.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1sgf | NERVE GROWTH FACTOR (Mus musculus) |
PF00089(Trypsin) | 6 | HIS G 57ASP G 189SER G 195TRP G 215GLY G 216GLY G 226 | None | 0.56A | 3gy3A-1sgfG:35.5 | 3gy3A-1sgfG:41.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1spj | KALLIKREIN 1 (Homo sapiens) |
PF00089(Trypsin) | 5 | HIS A 57ASP A 189SER A 195TRP A 215GLY A 216 | None | 0.60A | 3gy3A-1spjA:37.4 | 3gy3A-1spjA:42.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1spj | KALLIKREIN 1 (Homo sapiens) |
PF00089(Trypsin) | 5 | HIS A 57GLN A 174ASP A 189TRP A 215GLY A 216 | None | 0.93A | 3gy3A-1spjA:37.4 | 3gy3A-1spjA:42.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1thg | LIPASE 2 (Galactomycescandidus) |
PF00135(COesterase) | 5 | GLN A 470SER A 222TRP A 127GLY A 215GLY A 219 | None | 1.15A | 3gy3A-1thgA:undetectable | 3gy3A-1thgA:18.10 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ym0 | FIBRINOTIC ENZYMECOMPONENT B (Eisenia fetida) |
PF00089(Trypsin) | 8 | HIS A 57LEU A 99ASP A 189SER A 190SER A 195TRP A 215GLY A 216GLY A 226 | None | 0.43A | 3gy3A-1ym0A:36.0 | 3gy3A-1ym0A:39.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1zjk | MANNAN-BINDINGLECTIN SERINEPROTEASE 2 (Homo sapiens) |
PF00084(Sushi)PF00089(Trypsin) | 5 | HIS A 483SER A 633TRP A 655GLY A 656GLY A 667 | None | 0.63A | 3gy3A-1zjkA:28.8 | 3gy3A-1zjkA:26.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1zlr | COAGULATION FACTORXI (Homo sapiens) |
PF00089(Trypsin) | 6 | HIS A 57ASP A 189SER A 195TRP A 215GLY A 216GLY A 226 | 368 A 901 (-4.0A)368 A 901 (-2.8A)368 A 901 (-1.4A)None368 A 901 (-3.6A)368 A 901 (-3.5A) | 0.24A | 3gy3A-1zlrA:12.6 | 3gy3A-1zlrA:39.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2aip | PROTEIN C ACTIVATOR (Agkistrodoncontortrix) |
PF00089(Trypsin) | 5 | HIS A 57ASP A 189SER A 195GLY A 216GLY A 226 | SO4 A 301 (-3.8A)NoneSO4 A 301 (-2.8A)NoneNone | 0.64A | 3gy3A-2aipA:34.7 | 3gy3A-2aipA:39.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2eek | TRYPSIN-1 (Gadus morhua) |
PF00089(Trypsin) | 8 | HIS A 57ASP A 189SER A 190GLN A 192SER A 195TRP A 215GLY A 216GLY A 226 | NoneBEN A 301 (-2.7A)BEN A 301 (-2.8A)BEN A 301 (-4.1A)BEN A 301 (-3.4A)NoneBEN A 301 ( 3.8A)BEN A 301 (-3.2A) | 0.42A | 3gy3A-2eekA:40.6 | 3gy3A-2eekA:62.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2ei8 | COAGULATION FACTORX, HEAVY CHAIN (Homo sapiens) |
PF00089(Trypsin) | 6 | HIS A 57ASP A 189SER A 195TRP A 215GLY A 216GLY A 226 | NoneDT8 A 700 (-3.5A)DT8 A 700 ( 3.9A)DT8 A 700 (-3.9A)DT8 A 700 (-3.5A)DT8 A 700 (-3.5A) | 0.53A | 3gy3A-2ei8A:35.7 | 3gy3A-2ei8A:38.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2f91 | HEPATOPANCREASTRYPSIN (Astacusleptodactylus) |
PF00089(Trypsin) | 9 | HIS A 57LEU A 99ASP A 189SER A 190GLN A 192SER A 195TRP A 215GLY A 216GLY A 227 | None | 0.43A | 3gy3A-2f91A:36.4 | 3gy3A-2f91A:44.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2fge | ZINC METALLOPROTEASE(INSULINASE FAMILY) (Arabidopsisthaliana) |
PF00675(Peptidase_M16)PF05193(Peptidase_M16_C)PF08367(M16C_assoc) | 5 | LEU A 843ASP A 961TRP A 842GLY A 886GLY A 888 | None | 1.10A | 3gy3A-2fgeA:undetectable | 3gy3A-2fgeA:12.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2jet | CHYMOTRYPSINOGEN BCHAIN BCHYMOTRYPSINOGEN BCHAIN C (Rattusnorvegicus;Rattusnorvegicus) |
PF00089(Trypsin)PF00089(Trypsin) | 5 | HIS B 57SER C 195TRP C 215GLY C 216GLY C 226 | None | 0.64A | 3gy3A-2jetB:14.4 | 3gy3A-2jetB:38.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2oby | PUTATIVE QUINONEOXIDOREDUCTASE (Homo sapiens) |
PF00107(ADH_zinc_N)PF08240(ADH_N) | 5 | HIS A 314LEU A 39GLN A 46GLY A 62GLY A 94 | None | 1.20A | 3gy3A-2obyA:undetectable | 3gy3A-2obyA:21.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2oq5 | TRANSMEMBRANEPROTEASE, SERINE 11E (Homo sapiens) |
PF00089(Trypsin) | 7 | HIS A 57ASP A 189GLN A 192SER A 195TRP A 215GLY A 216GLY A 226 | NoneBEN A 245 (-3.0A)BEN A 245 (-4.4A)BEN A 245 (-3.3A)NoneBEN A 245 ( 3.8A)BEN A 245 (-3.4A) | 0.40A | 3gy3A-2oq5A:14.2 | 3gy3A-2oq5A:37.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2pka | KALLIKREIN AKALLIKREIN A (Sus scrofa;Sus scrofa) |
PF00089(Trypsin)PF00089(Trypsin) | 5 | HIS A 57ASP B 189SER B 195TRP B 215GLY B 216 | NoneBEN B 1 (-3.0A)BEN B 1 ( 4.0A)NoneBEN B 1 (-3.5A) | 0.38A | 3gy3A-2pkaA:10.7 | 3gy3A-2pkaA:22.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2pks | THROMBIN HEAVY CHAINFRAGMENT (Homo sapiens) |
PF00089(Trypsin) | 5 | ASP C 229SER C 235TRP C 257GLY C 258GLY C 268 | G44 C 101 (-2.6A)G44 C 101 (-3.5A)G44 C 101 (-4.1A)G44 C 101 (-3.3A)G44 C 101 (-3.0A) | 0.33A | 3gy3A-2pksC:11.8 | 3gy3A-2pksC:21.43 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2psy | KALLIKREIN-5 (Homo sapiens) |
PF00089(Trypsin) | 9 | HIS A 57GLN A 174ASP A 189SER A 190GLN A 192SER A 195TRP A 215GLY A 216GLY A 226 | None | 0.69A | 3gy3A-2psyA:37.8 | 3gy3A-2psyA:47.60 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2qy0 | COMPLEMENT C1RSUBCOMPONENT (Homo sapiens) |
PF00089(Trypsin) | 6 | HIS B 485ASP B 631SER B 637TRP B 659GLY B 660GLY B 668 | None | 0.45A | 3gy3A-2qy0B:11.7 | 3gy3A-2qy0B:32.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2r0l | HEPATOCYTE GROWTHFACTOR ACTIVATOR (Homo sapiens) |
PF00089(Trypsin) | 6 | HIS A 57ASP A 189SER A 195TRP A 215GLY A 216GLY A 226 | None | 0.32A | 3gy3A-2r0lA:17.9 | 3gy3A-2r0lA:37.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2r2w | PLASMINOGENACTIVATOR, UROKINASE (Homo sapiens) |
PF00089(Trypsin) | 7 | HIS U 57ASP U 189SER U 190GLN U 192TRP U 215GLY U 216GLY U 226 | 4PG U 300 (-3.9A)4PG U 300 (-2.8A)4PG U 300 (-2.7A)4PG U 300 (-3.7A)None4PG U 300 (-3.3A)4PG U 300 (-3.2A) | 0.48A | 3gy3A-2r2wU:14.9 | 3gy3A-2r2wU:39.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2r2w | PLASMINOGENACTIVATOR, UROKINASE (Homo sapiens) |
PF00089(Trypsin) | 7 | HIS U 57SER U 190GLN U 192SER U 195TRP U 215GLY U 216GLY U 226 | 4PG U 300 (-3.9A)4PG U 300 (-2.7A)4PG U 300 (-3.7A)4PG U 300 (-3.5A)None4PG U 300 (-3.3A)4PG U 300 (-3.2A) | 0.65A | 3gy3A-2r2wU:14.9 | 3gy3A-2r2wU:39.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2wpm | COAGULATION FACTORIXA HEAVY CHAIN (Homo sapiens) |
PF00089(Trypsin) | 8 | HIS S 57ASP S 189SER S 190GLN S 192SER S 195TRP S 215GLY S 216GLY S 226 | None | 0.71A | 3gy3A-2wpmS:13.4 | 3gy3A-2wpmS:41.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2zec | TRYPTASE BETA 2 (Homo sapiens) |
PF00089(Trypsin) | 7 | HIS A 59ASP A 203SER A 204SER A 209TRP A 229GLY A 230GLY A 240 | None11N A 1 (-2.6A)11N A 1 (-3.5A)11N A 1 (-3.3A)None11N A 1 (-3.9A)11N A 1 (-3.6A) | 0.33A | 3gy3A-2zecA:12.7 | 3gy3A-2zecA:40.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ab4 | ASPARTOKINASE (Corynebacteriumglutamicum) |
PF00696(AA_kinase)PF01842(ACT)PF13840(ACT_7) | 5 | LEU A 212ASP A 236SER A 174GLY A 178GLY A 238 | None | 1.18A | 3gy3A-3ab4A:undetectable | 3gy3A-3ab4A:19.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3beu | TRYPSIN (Streptomycesgriseus) |
PF00089(Trypsin) | 6 | HIS A 57ASP A 189SER A 195TRP A 215GLY A 216GLY A 226 | SO4 A 246 ( 3.8A)BEN A 247 (-3.0A)SO4 A 246 ( 2.5A)NoneBEN A 247 (-3.7A)BEN A 247 (-3.5A) | 0.33A | 3gy3A-3beuA:32.2 | 3gy3A-3beuA:36.93 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3f6u | VITAMIN K-DEPENDENTPROTEIN C HEAVYCHAIN (Homo sapiens) |
PF00089(Trypsin) | 6 | HIS H 57ASP H 189SER H 195TRP H 215GLY H 216GLY H 226 | 0G6 H 1 (-3.2A)0G6 H 1 (-2.8A)0G6 H 1 (-1.8A)0G6 H 1 (-4.1A)0G6 H 1 (-3.8A)0G6 H 1 ( 3.9A) | 0.56A | 3gy3A-3f6uH:33.8 | 3gy3A-3f6uH:36.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3gov | MASP-1 (Homo sapiens) |
PF00089(Trypsin) | 6 | HIS B 490ASP B 640SER B 646TRP B 668GLY B 669GLY B 679 | None | 0.48A | 3gy3A-3govB:34.7 | 3gy3A-3govB:35.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3gym | PROSTASIN (Homo sapiens) |
PF00089(Trypsin) | 7 | HIS A 57ASP A 189GLN A 192SER A 195TRP A 215GLY A 216GLY A 226 | None | 0.58A | 3gy3A-3gymA:34.5 | 3gy3A-3gymA:40.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3k7d | GLUTAMATE-AMMONIA-LIGASEADENYLYLTRANSFERASE (Escherichiacoli) |
PF03710(GlnE)PF08335(GlnD_UR_UTase) | 5 | LEU A 755SER A 877GLN A 860GLY A 689GLY A 692 | NoneNoneNoneSO4 A 16 ( 3.9A)None | 1.20A | 3gy3A-3k7dA:undetectable | 3gy3A-3k7dA:16.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3r3g | THROMBIN HEAVY CHAIN (Homo sapiens) |
PF00089(Trypsin) | 7 | HIS B 57LEU B 99ASP B 189SER B 195TRP B 215GLY B 216GLY B 226 | None | 0.48A | 3gy3A-3r3gB:32.8 | 3gy3A-3r3gB:37.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3s69 | THROMBIN-LIKE ENZYMEDEFIBRASE (Gloydiussaxatilis) |
PF00089(Trypsin) | 5 | HIS A 56ASP A 189SER A 195GLY A 212GLY A 223 | None | 0.52A | 3gy3A-3s69A:33.8 | 3gy3A-3s69A:44.05 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3w94 | ENTEROPEPTIDASE-1 (Oryzias latipes) |
PF00089(Trypsin) | 6 | HIS A 836ASP A 973SER A 974SER A 979GLY A1000GLY A1010 | None | 0.29A | 3gy3A-3w94A:36.8 | 3gy3A-3w94A:35.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4at0 | 3-KETOSTEROID-DELTA4-5ALPHA-DEHYDROGENASE (Rhodococcusjostii) |
PF00890(FAD_binding_2) | 5 | HIS A 268ASP A 474SER A 471GLY A 455GLY A 475 | FAD A1493 (-4.0A)NoneFAD A1493 (-2.7A)FAD A1493 (-3.5A)None | 1.16A | 3gy3A-4at0A:undetectable | 3gy3A-4at0A:16.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4bxw | FACTOR XA (Pseudonajatextilis) |
PF00089(Trypsin)PF14670(FXa_inhibition) | 6 | HIS A 211ASP A 356GLN A 359SER A 362GLY A 383GLY A 393 | 0GJ A1411 (-2.8A)0GJ A1411 (-2.7A)0GJ A1411 (-3.6A)0GJ A1411 (-1.4A)0GJ A1411 (-3.7A)0GJ A1411 (-3.3A) | 0.62A | 3gy3A-4bxwA:32.7 | 3gy3A-4bxwA:23.11 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4dgj | ENTEROPEPTIDASECATALYTIC LIGHTCHAIN (Homo sapiens) |
PF00089(Trypsin) | 6 | HIS A 41ASP A 181SER A 182GLN A 184GLY A 208GLY A 218 | None | 0.30A | 3gy3A-4dgjA:36.7 | 3gy3A-4dgjA:37.13 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4dgj | ENTEROPEPTIDASECATALYTIC LIGHTCHAIN (Homo sapiens) |
PF00089(Trypsin) | 6 | HIS A 41ASP A 181SER A 182SER A 187GLY A 208GLY A 218 | None | 0.63A | 3gy3A-4dgjA:36.7 | 3gy3A-4dgjA:37.13 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4e7n | SNAKE-VENOMTHROMBIN-LIKE ENZYME (Gloydius halys) |
PF00089(Trypsin) | 5 | HIS A 57ASP A 189SER A 195TRP A 215GLY A 216 | None | 0.61A | 3gy3A-4e7nA:12.8 | 3gy3A-4e7nA:41.99 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4fxg | MANNAN-BINDINGLECTIN SERINEPROTEASE 2 B CHAIN (Homo sapiens) |
PF00089(Trypsin) | 6 | HIS H 483ASP H 627SER H 628TRP H 655GLY H 656GLY H 667 | None | 0.59A | 3gy3A-4fxgH:32.8 | 3gy3A-4fxgH:36.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4iw4 | MANNAN-BINDINGLECTIN SERINEPROTEASE 3 (Homo sapiens) |
PF00089(Trypsin) | 6 | HIS E 478ASP E 639SER E 645TRP E 667GLY E 668GLY E 680 | None | 0.58A | 3gy3A-4iw4E:32.9 | 3gy3A-4iw4E:34.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4k8y | KALLIKREIN-4 (Homo sapiens) |
PF00089(Trypsin) | 6 | HIS A 57ASP A 189SER A 190SER A 195GLY A 216GLY A 226 | None | 0.43A | 3gy3A-4k8yA:36.6 | 3gy3A-4k8yA:40.89 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4k8y | KALLIKREIN-4 (Homo sapiens) |
PF00089(Trypsin) | 5 | LEU A 99ASP A 189SER A 190GLY A 216GLY A 226 | None | 0.76A | 3gy3A-4k8yA:36.6 | 3gy3A-4k8yA:40.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4lk4 | VESB PROTEASE (Vibrio cholerae) |
PF00089(Trypsin) | 5 | HIS A 78LEU A 122TRP A 239GLY A 240GLY A 251 | None | 0.54A | 3gy3A-4lk4A:27.1 | 3gy3A-4lk4A:26.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4m7g | TRYPSIN-LIKEPROTEASE (Saccharopolysporaerythraea) |
PF00089(Trypsin) | 7 | HIS A 42ASP A 173GLN A 176SER A 179TRP A 195GLY A 196GLY A 206 | None | 0.26A | 3gy3A-4m7gA:34.6 | 3gy3A-4m7gA:40.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4nff | KALLIKREIN-2 (Homo sapiens) |
PF00089(Trypsin) | 5 | HIS A 57ASP A 189SER A 195TRP A 215GLY A 216 | 0G6 A 301 (-2.7A)0G6 A 301 (-3.0A)0G6 A 301 (-1.4A)0G6 A 301 (-3.7A)0G6 A 301 (-3.4A) | 0.63A | 3gy3A-4nffA:38.5 | 3gy3A-4nffA:43.64 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4r0i | SUPPRESSOR OFTUMORIGENICITY 14PROTEIN (Homo sapiens) |
PF00089(Trypsin) | 8 | HIS A 57GLN A 175ASP A 189SER A 190SER A 195TRP A 215GLY A 216GLY A 226 | 3KM A 900 ( 4.4A)None3KM A 900 (-2.9A)3KM A 900 (-2.9A)3KM A 900 (-3.6A)None3KM A 900 (-3.4A)3KM A 900 (-3.2A) | 0.50A | 3gy3A-4r0iA:37.2 | 3gy3A-4r0iA:40.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4wwy | TRYPSIN-1 (Homo sapiens) |
PF00089(Trypsin) | 9 | HIS A 57LEU A 99ASP A 189SER A 190GLN A 192SER A 195TRP A 215GLY A 216GLY A 226 | None | 0.59A | 3gy3A-4wwyA:41.2 | 3gy3A-4wwyA:74.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4ylq | COAGULATION FACTORVII (Homo sapiens) |
PF00089(Trypsin) | 7 | HIS H 57ASP H 189SER H 190SER H 195TRP H 215GLY H 216GLY H 226 | 0Z7 H 501 (-2.6A)0Z7 H 501 (-2.3A)0Z7 H 501 (-2.3A)0Z7 H 501 (-1.4A)TMA H 508 ( 3.9A)0Z7 H 501 (-3.4A)0Z7 H 501 (-3.0A) | 0.40A | 3gy3A-4ylqH:35.2 | 3gy3A-4ylqH:40.34 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5brr | TISSUE-TYPEPLASMINOGENACTIVATOR (Homo sapiens) |
PF00089(Trypsin) | 5 | HIS E 57ASP E 189TRP E 215GLY E 216GLY E 226 | None | 0.44A | 3gy3A-5brrE:15.4 | 3gy3A-5brrE:37.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5eod | COAGULATION FACTORXI (Homo sapiens) |
PF00024(PAN_1)PF00089(Trypsin) | 5 | HIS A 413SER A 557TRP A 577GLY A 578GLY A 588 | None | 0.74A | 3gy3A-5eodA:24.8 | 3gy3A-5eodA:20.76 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5f8z | PLASMA KALLIKREINLIGHT CHAIN (Homo sapiens) |
PF00089(Trypsin) | 6 | HIS A 57ASP A 189SER A 195TRP A 215GLY A 216GLY A 226 | None | 0.42A | 3gy3A-5f8zA:17.2 | 3gy3A-5f8zA:41.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5gvt | PLASMA KALLIKREIN (Mus musculus) |
no annotation | 5 | HIS A 57ASP A 189SER A 195GLY A 216GLY A 226 | None | 0.56A | 3gy3A-5gvtA:11.9 | 3gy3A-5gvtA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5gvt | PLASMA KALLIKREIN (Mus musculus) |
no annotation | 5 | HIS A 57ASP A 189SER A 195TRP A 215GLY A 226 | None | 1.19A | 3gy3A-5gvtA:11.9 | 3gy3A-5gvtA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ihe | DNA POLYMERASE IISMALL SUBUNIT (Pyrococcusabyssi) |
PF00149(Metallophos) | 5 | HIS A 562GLN A 557ASP A 452GLY A 403GLY A 449 | FE A 702 ( 3.4A)NoneNoneNoneNone | 1.07A | 3gy3A-5iheA:undetectable | 3gy3A-5iheA:17.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ms3 | KALLIKREIN-8 (Homo sapiens) |
no annotation | 7 | HIS A 57GLN A 175ASP A 189SER A 195TRP A 215GLY A 216GLY A 226 | None | 0.62A | 3gy3A-5ms3A:38.3 | 3gy3A-5ms3A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5to3 | PROTHROMBIN,THROMBOMODULIN (Homo sapiens) |
PF00089(Trypsin)PF09064(Tme5_EGF_like) | 6 | HIS B 58LEU B 111ASP B 214SER B 220GLY B 243GLY B 253 | 0G6 B 501 (-2.5A)0G6 B 501 ( 3.8A)0G6 B 501 (-2.9A)0G6 B 501 (-1.3A)0G6 B 501 (-3.7A)0G6 B 501 (-3.6A) | 0.38A | 3gy3A-5to3B:16.2 | 3gy3A-5to3B:27.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5ubm | COMPLEMENT C1SSUBCOMPONENT (Homo sapiens) |
no annotation | 7 | HIS A 475ASP A 626SER A 627SER A 632TRP A 655GLY A 656GLY A 663 | None | 0.52A | 3gy3A-5ubmA:11.7 | 3gy3A-5ubmA:34.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5xrf | SNAKE VENOM SERINEPROTEASE DA-36 (Deinagkistrodonacutus) |
no annotation | 5 | HIS A 67ASP A 200SER A 206GLY A 223GLY A 234 | None | 0.69A | 3gy3A-5xrfA:13.3 | 3gy3A-5xrfA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5zfh | KALLIKREIN-7 (Mus musculus) |
no annotation | 5 | HIS A 57SER A 195TRP A 215GLY A 216GLY A 226 | None | 0.40A | 3gy3A-5zfhA:37.1 | 3gy3A-5zfhA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6b74 | COAGULATION FACTORXII (Homo sapiens) |
no annotation | 6 | HIS B 57ASP B 189SER B 195TRP B 215GLY B 216GLY B 226 | SO4 B 304 (-3.8A)BEN B 301 (-2.7A)SO4 B 304 ( 2.5A)NoneBEN B 301 (-3.3A)BEN B 301 (-3.1A) | 0.31A | 3gy3A-6b74B:13.7 | 3gy3A-6b74B:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6byw | GOXA (Pseudoalteromonasluteoviolacea) |
no annotation | 5 | LEU B 12GLN B 623TRP B 353GLY B 329GLY B 665 | None | 1.17A | 3gy3A-6bywB:undetectable | 3gy3A-6bywB:undetectable |